Differential impacts of fat and muscle mass on cardiovascular and non‐cardiovascular mortality in individuals with type 2 diabetes
Open Access
- 12 July 2024
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 15 (5) , 1930-1941
Abstract
Background: The distribution of fat and muscle mass in different regions of the body can reflect different pathways to mortality in individuals with diabetes. Therefore, we investigated the associations between whole‐body and regional body fat and muscle mass with cardiovascular disease (CVD) and non‐CVD mortality in type 2 diabetes (T2D).Methods: Within the National Health and Nutrition Examination Survey 1999–2006, 1417 adults aged ≥50 years with T2D were selected. Dual‐energy X‐ray absorptiometry was used to derive whole‐body, trunk, arm, and leg fat mass and muscle mass indices (FMI and MMI). Mortality data until 31 December 2019 were retrieved from the National Death Index. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated from Cox proportional hazard models.Results: A total of 1417 participants were included in this study (weighted mean age [standard error]: 63.7 [0.3] years; 50.5% female). Over a median follow‐up of 13.6 years, 797 deaths were recorded (371 CVD‐related and 426 non‐CVD deaths). Higher FMI in the arm was associated with increased risk of non‐CVD mortality (fourth quartile [Q4] vs. first quartile [Q1]: HR 1.82 [95% CI 1.13–2.94]), whereas higher FMI in the trunk or leg was not significantly associated with CVD or non‐CVD mortality. Conversely, higher arm MMI was associated with a lower risk of both CVD (Q4 vs. Q1: HR 0.51 [95% CI 0.33–0.81]) and non‐CVD (Q4 vs. Q1: HR 0.56 [95% CI 0.33–0.94]) mortality. There was a significant interaction between smoking status and arm FMI on non‐CVD mortality (P for interaction = 0.007). Higher arm FMI was associated with a higher risk of non‐CVD mortality among current or former smokers (Q4 vs. Q1: HR 2.67 [95% CI 1.46–4.88]) but not non‐smokers (Q4 vs. Q1: HR 0.85 [95% CI 0.49–1.47]).Conclusions: Fat mass and muscle mass, especially in the arm, are differently associated with CVD and non‐CVD mortality in people with T2D. Our findings underscore the predictive value of body compositions in the arm in forecasting mortality among older adults with T2D.Keywords
Funding Information
- China Scholarship Council (201907930017)
- Loo och Hans Ostermans Stiftelse för Medicinsk Forskning (2023‐01645)
This publication has 29 references indexed in Scilit:
- Predicted fat mass and lean mass in relation to all‐cause and cause‐specific mortalityJournal of Cachexia, Sarcopenia and Muscle, 2022
- Obesity paradox in associations between body mass index and diabetes-related hospitalization and mortality in patients with type 2 diabetes: Retrospective cohort studiesDiabetes & Metabolism, 2019
- Psoas and paraspinous muscle index as a predictor of mortality in African American men with type 2 diabetes mellitusJournal of Diabetes and its Complications, 2018
- Reduced muscle mass and accumulation of visceral fat are independently associated with increased arterial stiffness in postmenopausal women with type 2 diabetes mellitusDiabetes Research and Clinical Practice, 2016
- Total and regional adiposity measured by dual‐energy X‐ray absorptiometry and mortality in NHANES 1999‐2006Obesity, 2016
- Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseasesThe Lancet Diabetes & Endocrinology, 2014
- Body-Mass Index and All-Cause Mortality in US Adults With and Without DiabetesJournal of General Internal Medicine, 2013
- Mechanisms and Metabolic Implications of Regional Differences among Fat DepotsCell Metabolism, 2013
- Longitudinal changes in body composition associated with healthy ageing: men, aged 20–96 yearsBritish Journal of Nutrition, 2011
- Aging in adipocytes: Potential impact of inherent, depot-specific mechanismsExperimental Gerontology, 2007